Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3136 (LINC03136)
- Target
- LINC03136
- Molecular classification
- Long intergenic non-coding RNA, Noncoding RNA, Other (not a receptor, enzyme, transporter, transcription factor, or channel)
01
Overview
Long intergenic non-protein coding RNA 3136 (LINC03136; AP000842.3) is a noncoding RNA transcript identified in intergenic regions of the human genome. It is classified as a lincRNA—RNAs longer than 200 nucleotides, not overlapping protein-coding genes. LINC03136 is presumed to regulate gene expression, either at the level of chromatin remodeling, RNA-protein complex formation, or cis/trans transcriptional regulation. The biological functions and disease associations of this specific molecule are only inferred from studies of lincRNAs generally, as there is no direct experimental evidence describing the roles of LINC03136 in cell biology or pathology. LincRNAs, as a group, are increasingly recognized as important regulators of cellular processes and as contributors to cancer progression, prognosis, and complex disease phenotypes; they may serve as future therapeutic targets or biomarkers, but no such role for LINC03136 is currently established[3][1].
- Other names
- LINC03136AP000842.3
02
Mechanism of action
None
03
Biological functions
Regulation of gene expression (inferred from the lincRNA family’s function)May participate in chromatin remodeling, RNA-protein interactions, or regulation of neighboring gene expression[3][1].Other (precise functions of LINC03136 remain undefined; lincRNAs often regulate cell cycle, proliferation, stress response in context-dependent ways)
04
Disease associations
Cancer (lincRNAs as a class have been associated with cancer progression and prognosis, but no literature directly linking LINC03136 to a specific disease role was identified)[3]Other (potential involvement in gene regulation-related disorders is speculative)
05
Safety considerations
None
06
Interacting drugs
None
07
Biomarkers
None
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 3136 (LINC03136).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3136 (LINC03136).